発表論文 - 2026年

1. Sever B, Turkes C, Demir Y, Elamin KM, Osman W, Oral K, Genc SA, Canturk Z, Masunaga T, Kishimoto N, Misumi S, Otsuka M, Fujita M, and Ciftci H.
   Hydrazonylthiazole derivatives as dual EGFR and ALR2 inhibitors: Design, synthesis, and comprehensive in vitro and in silico evaluation for potential anticancer activity.
   Pharmaceuticals 19:50, 2026.